The National Institute for Health and Care Excellence (NICE) has approved teplizumab for use on the NHS for people with early-stage type 1 diabetes, marking the start of a new era in how we treat the ...

Dr Elizabeth Robertson, Diabetes UK's Director of Research and Clinical, shares her thoughts following the historic approval of the first type 1 diabetes immunotherapy on the NHS.

Type 2 diabetes causes Type 2 diabetes is high blood sugar levels caused by a lack of a hormone called insulin. Either your body isn’t making enough or the insulin it makes doesn’t work properly. This ...

What is the main treatment for type 2 diabetes? The main treatments for managing blood sugar levels if you have type 2 diabetes are: ...

Here are some of the exciting Diabetes UK events coming up across Wales, Scotland, Northern Ireland and England in July 2026, and how you can get involved.

Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...

Everything you need to know about type 2 diabetes remission. Find out what type 2 diabetes remission is, how it works, and what the benefits are.

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

We take a look at some of the exciting diabetes research developments announced in March 2026, and what the findings could mean for people living with or affected by diabetes.

UPDATE, 22 MAY 2024: We now have new information on the amount of people living with the diabetes, and for more information you can visit our guide on diabetes statistics. The number of people living ...